Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Placebo Controlled, Randomized, Double-Blind, Fixed-dose, Multicenter, Phase IIb Study to Investigate the Efficacy and Tolerability of BAY 58-2667 (50 μg/h, 100 μg/h, 150 μg/h) Given Intravenously to Subjects with Acute Decompensated Chronic Congestive Heart Failure (ADHF) within 12 hours after hospital admission (Pulmonary Artery Catheter eg, Swan-Ganz not required https://www.kusajili.fr:443/Trial/OAXGXw0SBE6HADpHj-WXlQ%24a-placebo-controlled-randomized-double-blind-fixed-dose-multicenter-phase-iib-study-to-investigate-the-efficacy-and-tolerabilit
I have read and accept the terms of use of the site and the Privacy Policy
Send your message